Delivery Order SPE2DB22D3501-SPE2DB25FVS43
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,575.16 firm-fixed-price delivery order is for the supply of 10,000 units/ml vials of PROCRIT, a medication, with an ultimate completion date of April 22, 2024. The contract is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROCRIT 20,000 unit/2 ML vials, a medication used to treat anemia. The contract has a ceiling value of $1,348.46 and is a firm fixed-price, non-set-aside contract. The ultimate completion date is April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.74 firm fixed-price delivery order is for the supply of 20,000 units/mL of the medication PROCRIT. The contract has an ultimate completion date of January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,617.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40,000 units/ml of the drug PROCRIT, a medication used to treat anemia. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a potential value of $2,060.80 and a completion date of January 26, 2024. It is for the delivery of 40,000 units/mL of PROCRIT, a pharmaceutical product, to a location in Conshohocken, Pennsylvania. This award is issued under a larger indefinite delivery contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,580.10, is for the delivery of 40,000 units of the medication PROCRIT 40,000 units/mL. The contract has a firm fixed price pricing type and an ultimate completion date of January 11, 2022. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is the prime contractor for this award. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM7X3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,525.82, is for the delivery of 4,567,331,044 units of PROCRIT 4,000 UNITS/ML VIALML. This is a Firm Fixed Price Delivery Order contract with a period of performance through February 21, 2025. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of PROCRIT 10,000 UNITS/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,571.44. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 4, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,288.54 firm-fixed-price delivery order is for the supply of 40,000 units of PROCRIT (Epoetin alfa) 40,000 units/mL vials. The contract has an ultimate completion date of August 14, 2024 and was awarded on August 13, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...